University of Texas Rio Grande Valley

ScholarWorks @ UTRGV
School of Medicine Publications and
Presentations

School of Medicine

10-2021

Real-Time Mobile Teleophthalmology for the Detection of Eye
Disease in Minorities and Low Socioeconomics At-Risk
Populations
Lama A. Al-Aswad
New York University School of Medicine

Cansu Yuksel Elgin
Vipul Patel
Deborah Popplewell
Kalashree Gopal

See next page for additional authors

Follow this and additional works at: https://scholarworks.utrgv.edu/som_pub
Digital
Part of the Health Information Technology Commons, and the Ophthalmology Commons
Commons
Network

Recommended Citation

Logo
Al-Aswad, L. A., Elgin, C. Y., Patel, V., Popplewell, D., Gopal, K., Gong, D., Thomas, Z., Joiner, D., Chu, C. K.,
Walters, S., Ramachandran, M., Kapoor, R., Rodriguez, M., Alcantara-Castillo, J., Maestre, G. E., Lee, J. H., &
Moazami, G. (2021). Real-Time Mobile Teleophthalmology for the Detection of Eye Disease in Minorities
and Low Socioeconomics At-Risk Populations. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.),
10(5), 461–472. https://doi.org/10.1097/APO.0000000000000416

This Article is brought to you for free and open access by the School of Medicine at ScholarWorks @ UTRGV. It has
been accepted for inclusion in School of Medicine Publications and Presentations by an authorized administrator
of ScholarWorks @ UTRGV. For more information, please contact justin.white@utrgv.edu,
william.flores01@utrgv.edu.

Authors
Lama A. Al-Aswad, Cansu Yuksel Elgin, Vipul Patel, Deborah Popplewell, Kalashree Gopal, Dan Gong, Zach
Thomas, Devon Joiner, Cha-Kai Chu, and Gladys E. Maestre

This article is available at ScholarWorks @ UTRGV: https://scholarworks.utrgv.edu/som_pub/422

ORIGINAL STUDY
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Purpose: To examine the benefits and feasibility of a mobile, real-time,
community-based, teleophthalmology program for detecting eye diseases
in the New York metro area.
Design: Single site, nonrandomized, cross-sectional, teleophthalmologic
study.
Methods: Participants underwent a comprehensive evaluation in a WiFi–equipped teleophthalmology mobile unit. The evaluation consisted of
a basic anamnesis with a questionnaire form, brief systemic evaluations
and an ophthalmologic evaluation that included visual field, intraocular
pressure, pachymetry, anterior segment optical coherence tomography,
posterior segment optical coherence tomography, and nonmydriatic
fundus photography. The results were evaluated in real-time and follow-up calls were scheduled to complete a secondary questionnaire form.
Risk factors were calculated for different types of ophthalmological
referrals.
Results: A total of 957 participants were screened. Out of 458 (48%)
participants that have been referred, 305 (32%) had glaucoma, 136 (14%)
had narrow-angle, 124 (13%) had cataract, 29 had (3%) diabetic retinopathy, 9 (1%) had macular degeneration, and 97 (10%) had other eye
disease findings. Significant risk factors for ophthalmological referral
consisted of older age, history of high blood pressure, diabetes mellitus,
Hemoglobin A1c measurement of 6.5, and stage 2 hypertension. As for
the ocular parameters, all but central corneal thickness were found to be
significant, including having an intraocular pressure >21 mm Hg, vertical
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cup-to-disc ratio 0.5, visual field abnormalities, and retinal nerve fiber
layer thinning.
Conclusions: Mobile, real-time teleophthalmology is both workable and
effective in increasing access to care and identifying the most common
causes of blindness and their risk factors.
Key Words: access to care, diabetes and hypertension, leading causes of
blindness, synchronies video consultation, teleophthalmology

(Asia Pac J Ophthalmol (Phila) 2021;10:461–472)

R

apid developments of telecommunication and information
technology in the last decade brought along a rising field of
medicine, that is, telehealth/telemedicine.1 Ophthalmology is a
specialty that lends itself well to the implementation of telemedicine because interpretations of screenings are routinely used for
diagnosis and prognosis of several eye diseases.2 Even though
teleophthalmology began to develop in rural and remote areas
with the idea of facilitating health care services for underserved
populations, there is also a great need for it in both urban
communities and high-income regions.3,4 The COVID-19 pandemic has showed how much essential it is.5 Although teleophthalmology is already accepted within the medical
community to improve eye care adherence and access, there is
still a great need for a teleophthalmologic protocol to detect the
most common eye diseases.
Although the field of eye care remains stable despite its
shortage of specialists, the growing population and the rise of oldage population leads to an exponential increase in follow-up
visits, which indicates that the demand for teleophthalmology
will continue to increase in the near future.6,7 We believe that an
effective, economic, and comfortable screening way of teleophthalmologic approach will be an inevitable means to reduce
hospital visits.
The objective of this pilot study is to examine the benefit and
feasibility of a real-time mobile teleophthalmology program for
screening of undetected eye diseases in the at-risk neighborhoods
of the metro area and provide an evaluation for this program. In
this program, vision test results were evaluated in real time and
remote consultation with an eye care professional was immediately available. Our team previously conducted urban-located,
community-based screenings with teleophthalmologic models to
better understand different systematic approaches.8,9 In the current study, a real-time mobile teleophthalmology program was
designed in the northern Manhattan of New York City. In a
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previous study using data from surrounding neighborhoods of
northern Manhattan, both at fixed sites and in a mobile unit, it is
shown that 25% of 8547 participants screened were glaucoma
suspects, 15% were deemed to need further investigation of ocular
diseases other than glaucoma, and 57% had never seen an eye
doctor in their lifetime.8,10 These rates are highly motivating for
further teleophthalmologic studies, including the current paper, to
detect public health originated problems and modeling ideal
teleophthalmologic modalities which, we believe, constitute an
emergent need. For the current study, we hypothesized that people
living in northern Manhattan were at risk of undiagnosed eye
disease and that it would be worthwhile to make vision-evaluating
services more readily accessible to them.

METHODS
This study adhered to the tenets of the Declaration of
Helsinki and was approved by the Columbia University Institutional Review Board.
Between June 2017 and November 2018, a Wi-Fi–equipped
teleophthalmology mobile unit toured neighborhoods in the metro
area (Fig. 1A). In some cases, the mobile unit was simply parked

on a street; in other cases, it was parked at a community center or
health fair. Flyers/handouts were distributed to announce the
scheduled time and location for free vision screening. No other
forms of recruitment were used. Subjects were not compensated
for participating in the study. The only inclusion criterion for the
study was to be 18 years of age or older.
In an isolated part of the mobile unit or hospital-affiliated
screening center, an explanation of the study was provided in
English to each prospective participant on a computer screen (or
in hard copy, if desired) and the information was also given
verbally. Alternatively, the explanation was available in Spanish, and Spanish-speaking staff members were present in the
mobile unit to explain further if necessary. Participants clicked
an “I Agree” button on the computer to indicate their willingness to participate, and this action generated a unique identification number. Three staff members including ocular
technicians and medical and college students screened each
participant as follows:
 Brief medical history taking that included self-identification of
ethnicity and race, address of residence, past medical, ocular,
and family histories including specific questions about diabetes

FIGURE 1. A, Teleophthalmology mobile unit. B, Inside of the mobile van.
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mellitus, hypertension, sleep apnea, hyperlipidemia, smoking
and dental examinations. This questionnaire was created to
help the evaluation of risk factors for major eye diseases.
After this medical history taking process, participants were
evaluated with basic systemic measurements such as:
 Height and weight measurement for calculation of body mass
index (BMI)
 Blood pressure measurement using an electronic sphygmomanometer
 Hemoglobin A1c (HbA1c) testing (Alere Afinion point-of-care
assay, Abbott, Abbott Park, IL)
Next, participants were taken to different stations for various
ocular screening:
 Visual acuity measurement using the Snellen chart (Titmus 2s
Vision Screener)
 Intraocular pressure (IOP) measurement via noncontact tonometry (Reichert 7CR Auto Tonometer, Cal Coast Ophthalmic
Instruments Inc., Torrance, CA)
 Anterior and posterior segment optical coherence tomography
(OCT) (3D OCT-1 Maestro, Topcon Medical Systems Inc.,
Oakland, NJ)
 Nonmydriatic fundus photography (3D OCT-1 Maestro, Topcon Medical Systems Inc., Oakland, NJ)
 Peripheral visual field measurement using frequency
doubling technology
The data obtained was entered and transmitted via a secure
Virtual Private Network connection to the Edward Harkness Eye
Institute reading center. The reading center is a centralized center
where all data is securely transmitted utilizing an internally built
data capturing system, imaging system, and video conferencing
system. An ophthalmologist or optometrist at the center analyzed
the data in real time. The eye care professional then video-conferenced in real time with the participant via Skype for Business,
which incorporates end-to-end encryption for voice and video, to
give recommendations for follow-up care. The conversation was
conducted in a private part of the mobile unit. Before leaving the
screening site, each participant received a printed copy of his or her
results and recommendations for follow-up care as well as a copy of
the informed consent form. Each participant also received a list of
eye care professionals whose offices were in or near their neighborhood. All the evaluations including anamnesis, basic systematic
measurements, ocular screenings, real-time video conference with
an eye care professional and information about follow-up recommendations, took about 20 minutes for each participant. All the
evaluations were performed in the efficient design mobile van
(Fig. 1B) and only one participant was taken into the mobile van at a
time to establish effective confidentiality.
To check follow-up rates and results within 2 to 4 months of
the screening, participants who were referred to an ophthalmic
examination were contacted by a patient navigator to ensure a
follow-up visit with a local eye doctor. If participants failed to
follow up, we inquired as to what prevented them from a followup to better understand the needs of the population.
The reading guidelines were prepared by an experienced
glaucoma specialist for an interpretation of the findings. An
experienced ophthalmologist or an optometrist analyzed the data
in real time and referred to participants according to defined
criteria.

ß 2021 Asia-Pacific Academy of Ophthalmology.
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Definitions
Glaucoma suspect:
 IOP >21 mm Hg with corneal thickness taken into consideration, and/or glaucomatous appearance of the optic disc and/or
an abnormal OCT consistent with glaucoma [deterioration of
double hump appearance, asymmetry between 2 eyes in retinal
nerve fiber layer (RNFL), generalized thinning in RNFL] and/
or a narrow angle on anterior segment OCT and/or frequency
doubling technology (FDT) abnormalities inconsistent with
retinal pathologies.
Narrow-angle suspect:
 Structurally assessed angles based on anterior segment OCT.
Angles were defined as narrow if they were 20 degrees on
anterior segment OCT. The narrow-angle suspect group is
categorized as a glaucoma suspect as well.
Cataract suspect:
 Visual acuity 20/40 with evidence of cataract on anterior
segment OCT
Diabetic retinopathy:
 Hemorrhages or exudates on 451 fundus photography
Diabetic state:
 Prediabetic state: HbA1c between 5.7% and 6.4%
 Diabetes: HbA1c 6.5% or above11
Blood pressure guidelines:
 Low blood pressure: Systolic 90 mm Hg or diastolic
60 mm Hg
 Normal: <120/80 mm Hg
 Elevated: Systolic 120–129 mm Hg and diastolic <80 mm Hg
 Stage 1 hypertension: Systolic 130–139 mm Hg or diastolic
80–89 mm Hg
 Stage 2 hypertension: Systolic 140 mm Hg or diastolic
90 mm Hg 12
BMI state:
 Obesity: BMI 30
 Above morbid obesity: BMI >40
The usual equation for calculating BMI (weight in pounds /
height in inches2) was adjusted to account for the fact that the
participants were clothed (2.65 for males; 1.76 for females).13
Data Analysis
Relative risk ratios (RRR) for each predictor and their
corresponding p-values were used for statistical inference. A
multivariate Bayesian logistic regression was performed to identify patient characteristics associated with possible abnormal
ophthalmic findings. A Bayesian approach to logistic regression
was chosen to specify the prior distribution of each continuous
variable and to avoid model overfitting. The regression model was
built from the full set of candidate predictor variables, that is, all
of the patient demographics and characteristics, and their pairwise
interactions. Computerized statistical analyses were conducted
using STATA software (version 14, StataCorp, College Station,
TX). The alpha level (type 1 error) was set to be 0.05.
RESULTS
Of 957 adults screened with 3828 total images, 3744
(97.81%) were readable images. No participant who wished to
be screened was turned away, and no one refused screening once
the study was explained. We eliminated 9 participants from the
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Age, mean  std
18 age 44, n (%)
45 age 54, n (%)
55 age 64
Age 65
Gender, n (%)
Female
Male
Ethnicity, n (%)
African American
Asian
Caucasian
Hispanic
Other
Self-declaration, n (%)
Insurance
Current smoker
Sleep apnea
Hypertension
Diabetes mellitus
Dyslipidemia
Glaucoma (all)
Cataracts
Macular degeneration
Retinal disorders
Last dental exam
<1 year
>2 years
>5 years
Never
Last eye exam
<1 year
>2 years
>5 years
Never

Characteristics
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383 (77%)
89 (18%)
49 (10%)
21 (4%)
13 (3%)
20 (4%)
12 (2%)
41 (8%)
3 (<1%)
6 (1%)

319 (64%)
117 (23%)
54 (11%)
9 (2%)

738 (77%)
182 (19%)
93 (10%)
383 (40%)
213 (22%)
302 (32%)
62 (6%)
113 (12%)
6 (<1%)
18 (2%)

622
213
108
14

(43%)
(33%)
(18%)
(6%)

178 (36%)
180 (36%)
97 (19%)
43 (9%)

142 (28%)
52 (10%)
35 (7%)
235 (47%)
35 (7%)

300 (31%)
94 (10%)
55 (6%)
443 (46%)
65 (7%)

407
317
171
61

278 (56%)
221 (44%)

519 (54%)
438 (46%)

(65%)
(22%)
(11%)
(1%)

54.49  13.01
104 (21%)
133 (27%)
136 (27%)
126 (25%)

Healthy Ocular
Findings
(n ¼ 499)

57.72  12. 92
142 (15%)
217 (23%)
318 (33%)
280 (29%)

Total
(n ¼ 957)

TABLE 1. Demographics and Patient Characteristics

(34%)
(9%)
(4%)
(45%)
(6%)

200 (44%)
108 (24%)
41 (9%)
6 (1%)

303 (66%)
96 (21%)
54 (11%)
5 (1%)

355 (78%)
93 (20%)
44 (10%)
219 (48%)
119 (26%)
163 (36%)
50 (11%)
72 (16%)
3 (<1%)
12 (3%)

158
42
20
208
28

241 (%)
217 (%)

61.24  11.87
38 (8%)
84 (18%)
148 (32%)
188 (41%)

Ophthalmology
Referred Patients
(n ¼ 458)

(35%)
(9%)
(5%)
(46%)
(6%)

154 (50%)
98 (32%)
41 (13%)
12 (4%)

196 (64%)
70 (23%)
36 (12%)
3 (1%)

231 (76%)
57 (19%)
26 (9%)
145 (48%)
71 (23%)
113 (37%)
44 (14%)
48 (16%)
3 (1%)
9 (3%)

107
26
14
140
17

162 (53%)
143 (47%)

61.6  11.25
17 (6%)
60 (20%)
104 (34%)
124 (41%)

Glaucoma
Suspects
(n ¼ 305)

65
43
22
6

(48%)
(32%)
(16%)
(4%)

87 (64%)
32 (24%)
16 (12%)
1 (<1%)

100 (74%)
27 (20%)
9 (7%)
52 (38%)
29 (21%)
46 (34%)
10 (7%)
12 (9%)
2 (1%)
3 (2%)

43 (32%)
11 (8%)
3 (2%)
68 (50%)
11 (8%)

85 (63%)
51 (38%)

59.74  9.61
6 (4%)
34 (25%)
53 (39%)
43 (32%)

Anatomic
Narrow Angle
Suspects (n ¼ 136)

(60%)
(25%)
(12%)
(2%)

(72%)
(19%)
(11%)
(56%)
(27%)
(36%)
(11%)
(24%)
(1%)
(2%)

(27%)
(10%)
(11%)
(48%)
(4%)

19 (66%)
4 (14%)
5 (17%)
1 (3%)

75
31
15
3

21
23
14
70
33
45
14
30
1
2

34
12
14
59
5

64 (52%)
60 (48%)

67.77  10.9
3 (2%)
12 (10%)
36 (29%)
73 (59%)

Cataract
Suspects
(n ¼ 124)

4 (44%)
2 (22%)
3 (33%)
0 (0%)

8 (89%)
1 (11%)
0 (0%)
0 (0%)

9 (100%)
2 (22%)
1 (11%)
1 (11%)
1 (11%)
1 (11%)
0 (0%)
3 (33%)
0 (0%)
0 (0%)

4 (44%)
4 (44%)
0 (0%)
1 (11%)
0 (0%)

7 (78%)
2 (22%)

67.89  11.49
0 (0%)
1 (11%)
3 (33%)
5 (56%)

AMD
Suspects
(n ¼ 9)

19 (66%)
4 (14%)
5 (17%)
1 (3%)

16 (55%)
9 (31%)
3 (10%)
1 (3%)

21 (72%)
7 (24%)
2 (7%)
18 (62%)
28 (97%)
14 (48%)
6 (21%)
14 (48%)
0 (0%)
4 (14%)

7 (24%)
1 (3%)
1 (3%)
18 (62%)
2 (7%)

11 (38%)
18 (62%)

62.31  9.55
1 (3%)
7 (24%)
9 (31%)
12 (41%)

Retinal
Disorders
Suspects (n ¼ 29)

54
21
20
2

66
14
17
0

86
17
10
44
31
32
5
12
1
5

27
10
3
46
9

(56%)
(22%)
(21%)
(2%)

(68%)
(14%)
(18%)
(0%)

(89%)
(18%)
(10%)
(45%)
(32%)
(33%)
(5%)
(12%)
(1%)
(5%)

(28%)
(10%)
(3%)
(47%)
(9%)

51 (53%)
46 (47%)

60.20  12.11
12 (12%)
16 (16%)
30 (31%)
39 (40%)

Other Ocular
Findings
(n ¼ 97)
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TABLE 2. Comparison of Self-Reported Diseases and Newly Detected Diseases

Condition

Disease Detected
by Screening (n ¼ 567)

Self-Reported
Within Condition

Newly Identified
Disease

Self-Reported Disease,
Not Identified by Screening

n ¼ 567
305
124
9
29
433
344

n ¼ 129
44
30
0
4
213
123

n ¼ 438
261
94
9
25
220
221

n ¼ 107
18
83
6
14
24
200

Ocular conditions (all)
Glaucoma (all)
Cataract
Macular degeneration
Retinal disorders (DRP and the others)
Diabetes or prediabetesy
Hypertension
DRP indicates diabetic retinopathy.


Patients who self-reported a history of cataracts. No differentiation between being preop or postop.

yPrediabetic state was defined as HbA1c 5.7%–6.4% and diabetes was defined as HbA1c  6.5%.

analysis because they did not finish the screening, or did not have
images taken (fundus photographs and OCT images).
The median age of the participants was 58 years and 54%
were female as shown in Table 1. The vast majority (93%) were
ethnic/racial minorities (nonwhite Hispanic, 46%; African American, 31%; Asian, 10%; Caucasian, 6%; others, 7%). Evidently,
the non-Hispanic and non–African American percentages in our
study group are relatively small. That is why even though the large
size of our study group would still allow some (but not strong)
statistical comparison across different ethnicities, we refrain from
doing so in the paper. Nevertheless, we should yield that this is a
limitation for our study. Sizeable percentages had other risk
factors for eye disease; close to one-third of the participants
reported dyslipidemia, close to one-fifth were current smokers,
and about 10% reported sleep apnea, which is a risk factor for
glaucoma.14 One-third of the participants had not had a dental
examination within 2 years (more than 5 years, 11%; never, 1%)
and nearly half (43%) had not had an eye examination within
1 year (more than 5 years, 18%; never, 6%).
Of the 957 participants whose data was analyzed, 380
participants (40%) were newly diagnosed and 458 (48%) were
referred for further ophthalmic evaluation. Of those, 305 (52%)
were glaucoma suspects, 124 (25%) cataracts, 29 (6%) diabetic
retinopathy, and 9 (1.8%) participants were macular degeneration
suspects.
Since this was a community-based screening study, the only
inclusion criterion for the study was to be 18 years of age or older.
All participants who may have an ocular disease were evaluated
with the same screening protocol as those who do not. Although
some of the participants had self-reported eye conditions or were
being monitored for a previously detected eye condition and
disease, the newly identified disease rate is quite high as shown
in Table 2; 261 of the glaucoma and 94 of the cataract suspects
were referred to an ophthalmic examination with a novel prediagnosis. In addition, from the mobile screening 244 (25%)
participants learned that they had diabetes or prediabetes and
183 (19%) of the study participants learned that they were
hypertensive.
Table 3 shows various systemic examination findings among
study participants, including HbA1c, systolic and diastolic blood
pressure, and BMI measurements. As expected, the highest value
of HbA1c, systolic blood pressure, and BMI were measured in the
diabetic retinopathy group.
Table 4 shows various ophthalmologic parameters in study
participants, including visual acuity (VA), intraocular pressure
(IOP), central corneal thickness (CCT), vertical cup-to-disc ratio

ß 2021 Asia-Pacific Academy of Ophthalmology.

(VCDR, measured by reader and OCT), RNFL thickness, and FDT
visual field (FDT-VF). Compared to those without any eye disease,
the mean IOP was higher in patients with suspected glaucoma
(14.56 mm Hg vs 16.89 mm Hg for the right eye, P value = 0.000,
similar for the left eye). The mean CCT in patients with suspected
glaucoma was similar to the mean CCT in healthy individuals
(P = 0.55). The mean RNFL was notably thinner in patients with
suspected glaucoma compared to the mean of the routine follow-up
cohort (97.71 vs 108.58 for the left eye, P = 0.000, similar for the
right eye). The cup-to-disc ratio in glaucoma suspects was larger on
average by 0.13 mm compared to the healthy individuals (P = 0.00
for both eyes). Overall, and in all subgroups of participants by eye
condition, the cup-to-disc ratio was greater when assessed by OCT
than when assessed by the readers.
In Table 5, the effect of all the ophthalmologic parameters
was evaluated using an RRR calculation for 5 different groups.
Besides the demographic characteristics, the risk factors were
grouped in 3 categories as: self-reported conditions, systemic
findings, and ocular findings. These risk factors were further
subdivided to 5 groups, ie, the groups with healthy ocular findings, and patients referred for a further ophthalmic evaluation,
glaucoma, narrow-angle, and cataract suspects.
For the participants, age older than 65, personal history of
hypertension, diabetes mellitus, glaucoma and cataract, presence
of regular eye doctor, reported eye injury/surgery, a HbA1c
measurement of 6.5, stage 2 hypertension, and as for the ocular
parameters, all but CCT; including an IOP 21 mm Hg, VCDR
0.5, VF abnormalities, and RNFL thinning, negatively impacted
the health status. All these parameters are associated with an
increase in the incidence of ocular finding.
Not surprisingly, these parameters are all associated with a
higher risk of being referred for a further ophthalmic evaluation,
as well as for being classified as a glaucoma suspect. Interestingly,
narrow-angle suspects who include the participants who have
anatomically narrow angle at 3 and 9 o’clock on anterior segment
OCT, have the only significant risk factors as age and female
gender. None of the ocular findings, systemic findings, or selfreported conditions were significant.
Significant factors associated with a higher risk for
cataract suspicion include age, personal history of hypertensionglaucoma-cataract, reported vision change, a HbA1c measurement
of 5.7, both low and high blood pressure measurement, VCDR
0.5 and RNFL thinning. However, ethnic groups relative to
Caucasians were found to be less at risk for cataract.
Table 6 presents the results of the Bayesian logistic regressions. The first 3 columns of Table 6 show the results of the
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543.31  39.14
544.54  38.96
0.33  0.14
0.34  0.14
0.53  0.18
0.54  0.19
109.99  11.61
108.58  11.72
0.86  2.23
0.81  2.31

0.37  0.18
0.38  0.18

0.56  0.20
0.56  0.21

105.17  16.70
104.19  16.94

1.56  3.23
1.69  3.68

14.46  3.11
14.56  3.16

15.13  4.23
15.27  4.46

544.56  40.43
545.19  40.41

0.26  0.28
0.27  0.29

0.31  0.32
0.35  0.42

Healthy Ocular
Findings
(n ¼ 499)

2.32  3.92
2.68  4.57

99.88  19.60
99.30  20.23

0.58  0.21
0.58  0.22

0.42  0.20
0.42  0.21

545.86  41.73
545.90  41.97

15.86  5.09
16.04  5.45

0.37  0.35
0.43  0.51

Ophthalmology
Referred Patients
(n ¼ 458)

1.79  3.32
2.12  4.05

98.82  20.28
97.71  20.51

0.62  0.21
0.63  0.20

0.46  0.21
0.47  0.22

545.89  40.61
547.07  41.12

16.79  5.50
16.89  6.00

0.34  0.32
0.41  0.50

Glaucoma
Suspects
(n ¼ 305)

1.15  2.76
1.23  3.08

105.40  16.79
105.57  16.64

0.57  0.19
0.58  0.18

0.38  0.18
0.38  0.18

546.45  39.84
547.95  39.50

15.65  4.46
15.77  4.33

0.29  0.20
0.33  0.40

Anatomic
NarrowAngle Suspects

Other Ocular
Retinal
Findings
Disorders
(n ¼ 97)
Suspects (n ¼ 29)

2.38  4.02
2.55  4.66

97.78  20.52
98.56  17.26

0.56  0.23
0.52  0.26

0.38  0.19
0.37  0.22

544.26  42.61
546.46  46.45

15.34  4.34
15.57  4.74

0.52  0.47
0.55  0.53

2.50  5.90
3.13  6.27

109.56  9.77
112.89  7.37

0.58  0.19
0.58  0.11

0.40  0.13
0.39  0.10

550.00  36.90
552.00  43.50

16.33  3.77
15.89  4.86

0.34  0.19
0.36  0.28

AMD
Suspects
(n ¼ 9)

6.14  6.05
5.96  6.43

97.59  23.18
92.17  25.00

0.50  0.25
0.54  0.24

0.42  0.20
0.46  0.21

559.31  32.04
545.70  27.19

15.10  4.62
15.46  5.31

0.67  0.52
0.74  0.73

Retinal
Disorders
Suspects (n ¼ 29)

3.79  4.34
4.46  5.37

100.63  20.21
100.03  20.21

0.52  0.22
0.53  0.23

0.35  0.16
0.36  0.17

548.77  38.17
550.68  34.97

13.80  3.45
14.07  3.49

0.35  0.36
0.34  0.31

Other Ocular
Findings
(n ¼ 97)

ß 2021 Asia-Pacific Academy of Ophthalmology.

fiber layer; VA, visual acuity; VCDR, vertical cup-to-disc ratio.

AMD indicates age-related macular degeneration; CCT, central corneal thickness; FDT-VF, frequency doubling technology visual field; IOP, intraocular pressure; OCT, optical coherence tomography; RNFL, retinal nerve

VA (logMAR), mean  std
Right eye
Left eye
IOP (mm Hg), mean  std
Right eye
Left eye
CCT (mm), mean  std
Right eye
Left eye
Reader: VCDR, mean  std
Right eye
Left eye
OCT: VCDR, mean  std
Right eye
Left eye
RNFL (mm), mean  std
Right eye
Left eye
FDT-VF (mm), mean  std
Right eye, avg misses
Left eye, avg misses

Ocular Variables

Total
(n ¼ 957)

TABLE 4. Results of Vision Testing from the Telemedicine Protocol

AMD
Suspects
(n ¼ 9)

6.12  1.25
5.74  0.36
8.72  2.14
6.03  1.45
25 (20%)
1 (11%)
0 (0%)
27 (28%)
23 (19%)
4 (44%)
2 (7%)
22 (23%)
50 (40%)
4 (44%)
4 (14%)
31 (32%)
26 (21%)
0 (0%)
23 (79%)
17 (18%)
134.97  21.48 125.56  23.67 137.69  24.75 126.48  19.79
78.77  11.35 73.67  12.13 79.76  10.58 76.18  10.32
3 (2%)
0 (0%)
0 (0%)
2 (2%)
26 (21%)
5 (56%)
8 (28%)
35 (36%)
44 (35%)
0 (0%)
5 (17%)
32 (33%)
12 (10%)
2 (22%)
3 (10%)
13 (13%)
36 (29%)
2 (22%)
11 (38%)
14 (14%)
3 (2%)
0 (0%)
2 (7%)
1 (1%)
28.38  6.68 28.36  8.76
30.58  6.76
27.71  5.71
40 (32%)
5 (56%)
4 (14%)
30 (31%)
45 (36%)
1 (11%)
11 (38%)
42 (43%)
39 (31%)
3 (33%)
14 (48%)
25 (26%)

Cataract
Suspects
(n ¼ 124)

Cataract
Suspects
(n ¼ 124)

5.94  1.18
27 (20%)
41 (30%)
47 (35%)
21 (15%)
128.93  20.32
78.10  11.01
2 (1%)
41 (30%)
45 (33%)
15 (11%)
33 (24%)
0 (0%)
28.16  6.29
39 (29%)
55 (40%)
42 (31%)

AMD indicates age-related macular degeneration; BMI, body mass index; BP, blood pressure; HbA1c, hemoglobin A1c; HT, hypertension.

6.14  1.44
6.15  1.48
108 (24%)
66 (22%)
112 (24%)
86 (28%)
147 (32%)
92 (30%)
90 (20%)
60 (20%)
130.74  20.72 130.50  20.13
79.27  11.67 79.47  11.77
5 (1%)
3 (1%)
131 (29%)
85 (28%)
136 (30%)
88 (29%)
53 (12%)
40 (13%)
128 (28%)
87 (29%)
5 (1%)
2 (1%)
28.05  5.66
27.89  5.46
138 (30%)
94 (31%)
187 (41%)
123 (40%)
133 (29%)
88 (29%)

Healthy Ocular Ophthalmology Glaucoma Anatomic NarrowAngle Suspects
Referred Patients Suspects
Findings
(n ¼ 136)
(n ¼ 305)
(n ¼ 458)
(n ¼ 499)

HbA1c, mean  std
5.96  1.26
5.79  1.03
Healthy A1C (Under 5.3), n (%)
243 (25%)
135 (27%)
Treading towards prediabetes (5.4–5.6), n (%) 279 (29%)
167 (33%)
Prediabetic state (5.7–6.4), n (%)
289 (30%)
142 (28%)
Diabetic (6.5), n (%)
144 (15%)
54 (11%)
Systolic BP, mean  std
128.8  19.66 127.02  18.47
Diastolic BP, mean  std
78.81  12.02 78.39  12.33
Low BP, n (%)
10 (1%)
5 (1%)
Normal BP, (%)
314 (33%)
184 (37%)
Pre-HT, n (%)
266 (28%)
130 (26%)
Stage 1 HT, n (%)
115 (12%)
62 (12%)
Stage 2 HT, n (%)
243 (25%)
115 (23%)
Hypertensive urgency, n (%)
8 (<1%)
3 (<1%)
BMI, mean  std
28.36  5.86 28.64  6.03
Normal range (18.5–24.9), n (%)
265 (28%)
127 (25%)
Elevated (25–29.9), n (%)
393 (42%)
206 (41%)
High (30), n (%)
299 (31%)
166 (33%)

Systematic Variables

Total
(n ¼ 957)

TABLE 3. Results of Vision Testing from the Telemedicine Protocol

Al-Aswad et al
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Age (relative to group age 18–44)
45 age 54
55 age 64
Age 65
Gender (relative to male)
Female
Ethnicity (relative to Caucasian)
Hispanic
African American
Asian
Others
Self-report Conditions
Presence of insurance
Smoking
Sleep apnea
Personal history of hypertension
Personal history of DM
Personal history of dyslipidemia
Personal history of glaucoma
Personal history of cataract
Last dental exam (related to less than 1 year)
Last dental exam >2 years
Last dental exam >5 years
Last dental exam never
Last eye exam (related to last eye
exam less than 1 year)
Last eye exam >2 years
Last eye exam >5 years
Last eye exam never
Presence of regular eye doctor
Reported vision change
Reported eye injury / surgery
Systemic Findings
BMI (related to normal range 18.5–24.9)
BMI elevated (25–29.9)
BMI high (30)
HbA1c (related to healthy A1C
level <5.3)
HbA1c: Treading towards prediabetes
(5.4–5.6)
HbA1c: Prediabetic state (5.7–6.4)
HbA1c: Diabetic (6.5 and higher)
Blood pressure (related to normal
blood pressure)
Prehypertension
Stage 1 hypertesion

ß 2021 Asia-Pacific Academy of Ophthalmology.

0.34
0.10
0.01
0.31
0.28
0.77
0.34
0.91
0.00
0.01
0.01
0.00
0.00
0.35
0.81
0.27
0.00
0.00
0.00
0.00
0.20
0.01

1.06 (0.94–1.20)
(0.67–1.04)
(0.59–0.94)
(0.66–1.14)
(0.63–1.14)

0.83
0.74
0.87
0.85

0.98 (0.85–1.13)
0.92 (0.79–1.09)
1.01 (0.83–1.24)
0.73 (0.64–0.84)
0.81(0.69–0.96)
0.84 (0.73–0.96)
0.35 (0.21–0.59)
0.67 (0.52–0.86)

1.07 (0.92–1.24)
0.97 (0.80–1.20)
1.25 (0.84–1.87)

1.30
1.30
1.61
0.77
0.92
0.80
0.26
0.07
0.32
0.14
0.00
0.02
0.42

1.09 (0.93–1.28)
1.16 (0.99–1.36)

1.08 (0.93–1.25)

0.88 (0.25–1.04)
0.67 (0.53–0.87)

0.84 (0.72–0.98)
0.92 (0.76–1.12)

(1.12–1.50)
(1.09–1.54)
(1.32–1.96)
(0.67–0.89)
(0.82–1.04)
(0.68–0.95)

0.02
0.00
0.00

0.84 (0.72–0.97)
0.65 (0.56–0.76)
0.54 (0.46–0.65)

(0.87–1.20)
(0.92–1.27)
(0.79–1.24)
(1.21–1.56)
(1.06–1.41)
(1.05–1.37)
(1.53–2.04)
(1.19–1.63)

(0.90- 1.86)
(1.01–2.09)
(0.81–1.86)
(0.82- 1.97)

(0.66–0.89)
(0.63–0.93)
(0.35–0.78)
(1.14–1.49)
(0.95–1.25)
(1.07–1.43)

1.23 (1.03–1.47)
1.11 (0.87–1.40)

1.14 (0.96–1.37)
1.41 (1.16–1.70)

0.90 (0.74–1.10)

0.91 (0.78–1.07)
0.85 (0.72 -1.01)

0.77
0.77
0.52
1.30
1.09
1.24

0.93 (0.78–1.10)
1.03 (0.84–1.26)
0.73 (0.36–1.49)

1.02
1.08
0.99
1.37
1.23
1.19
1.77
1.39

1.29
1.45
1.23
1.27

0,94 (0.82–1.07)

1.45 (1.05–1.99)
1.97 (1.45–2.61)
2.24 (1.68–2.98)

0.02
0.40

0.14
0.00

0.32

0.26
0.07

0.00
0.01
0.00
0.00
0.20
0.00

0.37
0.80
0.39

0.78
0.32
0.91
0.00
0.00
0.01
0.00
0.00

0.17
0.05
0.33
0.29

0.34

0.02
0.00
0.00

Ophthalmology
Healthy
Referred Patients
Ocular Findings
RRR (95%)
P value
RRR (95%)
P value

TABLE 5. Results of Relative Risk Ratio from the Telemedicine Protocol

(0.77–1.99)
(0.87–2.26)
(0.62–1.90)
(0.60- 1.98)

(0.66–1.00)
(0.47–0.85)
(0.30–0.88)
(1.00–1.48)
(0.81–1.17)
(1.01–1.53)

1.23 (0.96–1.57)
1.29 (0.95–1.76)

1.17 (0.90–1.53)
1.53 (1.16–2.03)

1.13 (0.87–1.49)

0.88 (0.71–1.10)
0.83 (0.65–1.05)

0.82
0.63
0.52
1.22
0.97
1.24

1.04 (0.83–1.31)
1.06 (0.79–1.41)
0.68 (0.25–1.87)

0.93 (0.75- 1.15)
0.98 (0.77–1.24)
0.87 (0.62–1.22)
1.36 (1.13–1.63)
1.06 (0.85–1.32)
1.28 (1.06–1.54)
2.43 (2.01–2–94)
1.39 (1.10–1.77)

1.24
1.40
1.09
1.09

0.96 (0.79–1.15)

2.31 (1.41–3.79)
3.06 (1.91–4.90)
3.30 (2.07–5.26)

Glaucoma
Referred

0.11
0.11

0.24
0.00

0.36

0.26
0.13

0.06
0.00
0.01
0.05
0.77
0.04

0.77
0.71
0.45

0.51
0.86
0.41
0.00
0.60
0.01
0.00
0.01

0.37
0.17
0.77
0.78

0.64

0.00
0.00
0.00

P value

(0.59- 1.20)
(0.71–1.56)
(0.35–1.25)
(0.67–1.28)
(0.65–1.39)
(0.80–1.54)
(0.63–2.06)
(0.41–1.26)

(0.59–1.21)
(0.51–1.26)
(0.28–1.36)
(0.79–1.54)
(0.85–1.62)
(0.70–1.49)

1.29 (0.88–1.92)
1.00 (0.58–1.74)

1.46 (0.94–2.28)
1.31 (0.77–2.23)

1.32 (0.84–2.08)

0.95 (0.65–1.39)
0.95 (0.64–1.43)

0.85
0.81
0.62
1.10
1.18
1.02

1.07 (0.74–1.56)
1.06 (0.65–1.73)
0.51 (0.08–3.41)

0.84
1.05
0.66
0.93
0.95
1.11
1.14
0.72

2.81 (0.92–8.64)
2.63 (0.85–8.17)
2.15 (0.63–7.36)
3.10 (0.91–10.56)

1.41 (1.02–1.94)

3.71 (1.60- 8.60)
4.42 (1.95–10.03)
3.24 (1.41- 7.44)

Narrow-Angle
Referred

0.19
0.99

0.09
0.32

0.23

0.80
0.82

0.37
0.35
0.23
0.58
0.33
0.92

0.71
0.82
0.49

0.34
0.79
0.20
0.65
0.78
0.54
0.65
0.25

0.07
0.10
0.23
0.07

0.04

0.00
0.00
0.01

P value

(0.36–0.82)
(0.47–1.16)
(0.27–1.30)
(0.72–1.47)
(1.20–2.49)
(0.70–1.54)

2.00 (1.27–3.16)
1.26 (0.66–2.42)

1.68 (1.07–2.63)
1.76 (1.06–2.92)

0.80 (0.47–1.37)

0.76 (0.51–1.13)
0.86 (0.57–1.30)

0.55
0.74
0.59
1.03
1.73
1.04

1.21 (0.82–1.78)
1.15 (0.69–1.93)
1.78 (0.64–4.95)

0.92 (0.63–1.35)
0.97 (0.64–1.48)
1.18 (0.71–1.98)
1.94 (1.40–2.70)
1.27(0.88–1.83)
1.24 (0.88–1.74)
1.84 (1.12–3.00)
2.38 (1.66–3.42)

0.52 (0.31– 0.87)
0.45 (0.26– 0.77)
0.50 (0.25–1.00)
0.30 (0.12–0.79)

0.90 (0.65–1.25)

2.62 (0.75–9.11)
5.17 (1.61–16.61)
11.76 (3.78–36.62)

Cataract
Referred

0.00
0.48

0.02
0.03

0.42

0.17
0.48

0.00
0.19
0.19
0.89
0.00
0.86

0.34
0.59
0.27

0.67
0.89
0.52
0.00
0.21
0.22
0.02
0.00

0.01
0.00
0.05
0.01

0.53

0.13
0.01
0.00

P value
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(0.17–0.41)
(0.51–0.70)
(0.11–0.39)
(0.72–0.94)
(0.58–0.79)
(0.58–0.75)
(0.02–0.21)
(0.35–0.54)
(0.94–1.20)
(0.85–1.14)

0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.34
0.81

1.99 (1.78–2.22)
1.60 (1.41–1.82)
1.99 (1.78–2.22
1.27 (1.05–1.53)
1.45 (1.27–1.64)
1.36 (1.28–1.46)
2.04 (1.84–2.21)
1.88 (1.67–2.12)
0.94 (0.82–1.07)
1.02 (0.87–1.19)

0.00
0.00
0.00
0.01
0.00
0.00
0.00
0.00
0.35
0.81

(2.30–3.18)
(2.09–3.01)
(2.66–3.56)
(1.38–2.57)
(1.89–2.69)
(1.10–1.36)
(2.35–3.24)
(2.07–2.93)
(0.75–1.09)
(0.86–1.33)

0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.31
0.56
2.70
2.50
3.08
1.89
2.26
1.22
2.76
2.46
0.91
1.07
0.27
0.60
0.21
0.82
1.68
0.66
0.07
0.44
1.06
0.98
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BMI indicates body mass index; CCT, central corneal thickness; FDT, frequency doubling technology; HbA1c, hemoglobin A1c; IOP, intraocular pressure; OCT, optical coherence tomography; RNFL, retinal nerve fiber
layer; RRR, relative risk ratios; VA, visual acuity; VF, visual field; VCDR, vertical cup-to-disc ratio.

0.00
0.21
0.02
0.99
0.48
0.07
0.00
0.00
0.68
0.91
(1.28–2.78)
(0.89–1.73)
(1.07–2.75)
(0.66–1.51)
(0.80–1.60)
(0.98–1.47)
(1.74–3.79)
(1.33–2.57)
(0.77–1.49)
(0.66–1.46)
0.13
0.54
0.79
0.22
0.94
0.13
0.32
0.76
0.13
0.68
(0.91–2.08)
(0.80–1.53)
(0.51–1.68)
(0.85–2.01)
(0.71–1.38)
(0.66–1.06)
(0.78–2.14)
(0.75–1.50)
(0.57–1.07)
(0.75–1.56)

1.89
1.24
1.72
1.00
1.13
1.20
2.57
1.85
1.07
0.98

0.51
1.54 (0.43–5.48)

1.37
1.11
0.92
1.31
0.99
0.83
1.29
1.06
0.78
1.08

P value
0.85
Narrow-Angle
Referred
1.04 (0.68–1.60)

Glaucoma
Referred
P value
1.33 (1.04–1.70)
0.03
0.93 (0.28–3.12)
0.90
1.11 (0.42–2.92)
0.83
Healthy
Ophthalmology
Ocular Findings
Referred Patients
RRR (95%)
P value
RRR (95%)
P value
0.81 (0.69–0.95)
0.01
1.27 (1.06–1.51)
0.01
0.64 (0.26–1.58)
0.33
1.50 (0.86–2.61)
0.15
0.86 (0.46–1.60)
0.63
1.20 (0.64–2.27)
0.57

Stage 2 hypertesion
Hypertensive urgency
Low blood pressure (hypoTA)
Ocular Findings (in either eye)
IOP >21mm Hg
VCDR 0.5 according to specialist
VCDR 0.7 according to specialist
VCDR 0.5 according to OCT
VCDR 0.7 according to OCT
VF (FDT) abnormality
RNFL <75 mm
RNFL <95 mm
CCT <535 mm
CCT <510 mm

TABLE 5. (Continued)

Cataract
Referred
1.79 (1.12–2.89)
4.54 (1.73–11.95)
3.63 (1.32–10.04)

P value
0.02
0.00
0.01

Al-Aswad et al

regressions of being referred for further evaluation and the
remaining 3 columns do the same for glaucoma suspicion.
According to the presented results, aging, HbA1c, being previously treated for glaucoma, high IOP and low RNFL are all
associated with a higher probability of being referred. The same
factors are also significant for glaucoma suspicion.
As shown in Table 7, telephone follow-up was successful for
only 38% of participants with cataracts, 38% with glaucoma, 30%
narrow angles, 48% with retinal disorders, and none with macular
degeneration. Besides, detected additional eye problems and
disease confirmation rates were shown in Table 7.

DISCUSSION
Our data indicate that 380 participants (40%) were newly
diagnosed. 458 (48%) participants were detected for having at
least 1 eye condition requiring treatment or control by an eye care
specialist. It is worth emphasizing that this is not in an underserved neighborhood. Our team’s previous studies that were done
in the same area showed that this ratio is 40.79% for an abnormal
eye condition,9 and in another study, the percentage of the patients
who were referred just for glaucoma evaluation was 25%.8 These
rates were mainly described only as anatomically based abnormalities detected by comprehensive screening models and IOP
measurements and perimetry. One should yield that peripheral
retinal pathologies, corneal - lenticular - anterior segment pathologies require biomicroscopic evaluations, and therefore might be
easily missed.
In this study, both the prevalence of detected ophthalmologic
pathologies (48%) and newly diagnosed ocular conditions (40%)
are absolutely higher compared to the results of similar studies.
The prevalence of asymptomatic, newly diagnosed eye disease is
14% to 33% of patients in a great majority of the studies.15–18 It
must be emphasized that, these studies are mainly retrospective
analyses of optometry clinic documentations, 3 of which included
subjects originating from spectacle prescription applications15–17
and 1 included patients who were regular users of general medical
services.18 The only teleophthalmologic study that aimed to detect
abnormal ocular conditions is the study of Grau et al in occupational medicine,19 but in this study, only 13.47% of the workers
examined, whose ocular findings necessitating treatment or control by an ophthalmologist, were performed. Different from ours,
this was based on an occupational medical study in Germany with
a strikingly different population than ours and including insured
subjects from working age population who are not largely coming
from different ethnic origins contrary to our study.
The highest prevalence of abnormal ocular condition in
literature is seen in our study. There might be several reasons
that might contribute to this high rate. The high-risk populations
in our subject pool have inadequate health insurance, irregular eye
care, and ethnic and systemic risk factors. The participants
screened for eye diseases in this pilot study, of whom 93% are
racial or ethnic minority group, were confirmed to be considered
underserved. 23% of these individuals did not have health insurance and more than half of them (57%) had not had an eye
examination within the past year, including 18% who could not
recall an eye examination within the past 5 years. An additional
6% said they had never had an eye examination. A similar report
was published by Wang et al,18 who found that a substantial
portion of the primary care clinic population (50%) in an urban
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TABLE 6. Bayesian Regression of Ophthalmological Referral (1,2,3) and Glaucoma Referral (4,5,6)

Variables
Age
Hispanic
African American
Asian
Others
HbA1c
Treated glaucoma
IOP >21mm Hg
RNFL <95 mm
VF Abnormal
Constant
Observations

(1)
Oph. Ref.

(2)
Oph. Ref.

(3)
Oph. Ref.

(4)
Glauc. Ref.

(5)
Glauc. Ref.

(6)
Glauc. Ref.

0.04
(0.01)
0.63
(0.33)
0.97
(0.33)
0.57
(0.38)
0.94
(0.42)
0.61
(0.21)
1.26
(0.32)
2.10
(0.28)

0.04
(0.01)
0.71
(0.34)
1.02
(0.35)
0.60
(0.40)
1.00
(0.43)
0.51
(0.22)
1.04
(0.32)
2.04
(0.29) 1.05 (0.18)

0.04
(0.01)
0.53
(0.40)
0.82
(0.40)
0.38
(0.45)
0.62
(0.49)
0.41
(0.21)
1.54
(0.31)
1.98
(0.23)

0.02
(0.01)
0.61
(0.41)
0.84
(0.42)
0.42
(0.47)
0.68
(0.50)
0.27
(0.22)
1.30
(0.32)
1.92
(0.24) 1.12 (0.18)

-3.76
(0.49)
956

-3.53
(0.49)
956

0.04
(0.01)
0.70
(0.40)
1.00
(0.40)
0.65
(0.46)
1.07
(0.48)
0.58
(0.26)
0.66
(0.37)
2.39
(0.35) 0.80 (0.21)
0.66
(0.11) -3.96
(0.55)
784

-3.92
(0.55)
956

-3.60
(0.54)
956

0.03
(0.01)
0.60
(0.48)
0.86
(0.48)
0.43
(0.53)
0.79
(0.56)
0.48
(0.24)
1.17
(0.35)
2.27v
(0.28) 0.89 (0.20)
0.15
(0.10) -3.86
(0.60)
784

Robust standard errors in parentheses.
HbA1c indicates hemoglobin A1c; IOP, intraocular pressure; RNFL, retinal nerve fiber layer; VF, visual field.

P < 0.01


P < 0.05



P < 0.1

community had undiagnosed ocular diseases and concluded that
regular ophthalmic screenings would be required especially for
patients who were over 65 years, were in poor health, had not had
routine vision exams, or who did not have adequate insurance
coverage. Their infrequent eye examinations, inadequate insurance coverage for eye care, and poor general health were considered to be relevant factors for the detection of ocular diseases.
Another study, the Los Angeles Latino Eye Study, is yet another
population-based study to detect undiagnosed eye diseases among
Latinos finding out that any type of eye disease or refractive error
frequency to be 53% in a population of older than 40.20 Ethnicity,
education, lack of insurance, insurance coverage, lack of regular
eye examination, and comorbidities were found to be significant
factors in this regard. Therefore, there is a need to develop better
strategies to educate the population about the importance of vision
screenings and management of ocular diseases, especially as our
population ages and the prevalence of diseases increases in the
near future. This type of study can also help plan targeted
educational awareness-raising campaigns to improve public
health.

Another possible reason for the high rate of detection of the
abnormal ocular conditions might be the comprehensiveness of
our screening. Although a comprehensive screening generally
assists clinicians in catching asymptomatic, mild diseases, it can
also lead to false positivits.21,22 We modeled the screening
protocol of our study using comprehensive tests as an aid, to
prediagnose and to refer effectively to a definite examination. We
used “either positive rule” for glaucoma references (the major part
of the referenced group) if either structural test, functional test, or
IOP was outside normal limits. Unexpectedly, more than onethird of participants had these criteria and were referred to a
further ophthalmic examination as a glaucoma suspect. Largescale population-based glaucoma screening studies on 40 years
and older showed that the prevalence of patients referred for
additional testing and ophthalmic examination is between 10%33%23–25 and this is also less than our rate. These studies were not
performed with a teleophthalmologic approach. Also, they did not
include detailed anterior and posterior segment OCT screening for
the RNFL and macula to catch early preperimetric glaucoma and
narrow-angle glaucoma suspects.

TABLE 7. Individual Follow-up

Disease, n

Reached,
n (%)

Followed Up With
Ophthalmologist, n (%)

Cataract, n ¼ 124
Glaucoma, n ¼ 305
Narrow angle, n ¼ 136
Retinal disorders, n ¼ 29
Macular degeneration, n ¼ 9

47 (38%)
117 (38%)
41 (30%)
14 (48%)
0 (0%)

39 (83%)
82 (70%)
41 (100%)
10 (71%)
0 (0%)

Disease
Confirmed,
n (%)
16
50
18
11
0

(34%)
(42%)
(44%)
(79%)
(0%)

Additional
Eye Problem
Detected, n (%)
7 (15%)
20 (17%)
25 (61%)
6 (43%)
NA

Required
Rx, n (%)
3
0
0
0

(6%)
(0%)
(0%)
(0%)
NA

NA indicates not applicable; Rx ¼ Prescription for glasses.


Percentage based on patients reached.
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In our study, glaucoma suspects are the largest group among
all referrals. Similar to our study, the largest referred group
(38.7%) in Maa et al26 is made up of glaucoma suspects. A high
rate of glaucoma referral, complicated with asymptomatic early
stages of glaucoma, led Maa et al to further their research with the
next parts of their Technology-based Eyecare Services (TECS)
study to establish consensus upon diagnosis. The TECS protocol
was powered for glaucoma/glaucoma suspect detection at the first
part27 and impact of OCT on the accuracy of the TECS protocol at
the second part.28 These teleophthalmologic approaches
prompted us to keep the definition criteria as sensitive as possible
and to construct an OCT integrated model.
We used glaucoma suspect as an umbrella term to include all
glaucoma possibilities (probable-definite, possible, likely) in a
group of healthy participants who face risk factors for glaucoma
(IOP >21mm Hg, narrow angle on anterior segment OCT, etc) or
mimic glaucomatous appearance. Diagnosing glaucoma still
remains a challenge as there is no single litmus test that can
reliably tell whether glaucomatous changes are present. Even in
the clinic, a definitive examination and the diagnosis of glaucoma is multifactorial and includes IOP, CCT, VF, disc appearance, OCT-RNFL findings, all of which were performed in this
study. Despite all these factors, we should also yield that there is
no single and definite consensus on glaucoma diagnosis parameters. Luckily, for most patients, these definitive parameters
make the condition obvious that they either have or do not have
glaucoma and they display objective documentation of the disease
status. However, the detection of early glaucoma still remains
challenging, as there is a significant overlap between normal
variants and factors leading to an early detection of disease.
Therefore, multiple diagnostic tests may play a massive role to
overcome uncertainty. On the other hand, healthy subjects may still
be categorized as glaucoma suspects due to “statistical
abnormality” of outputs of diagnostic devices. Clinician affinity
and over-reliance on newer diagnostic devices may lead to overdiagnosing glaucoma if findings are interpreted in isolation without
taking into consideration the complete clinical scenario.22,29 Previous studies have also shown that the diagnostic accuracies of
screening tests can vary with the severity of the disease and that the
performance of the tests tail off from advanced to mild stage.30–32
The accuracy of tests may also vary according to the population
characteristics.29 However, one should keep in mind that these
previous studies were based at clinics, unlike our randomly sampled, population screening teleophthalmolgic model. This difference is especially important when one considers Maul and Jampel33
who argue a diagnostic test will not perform as well in the real
world, even more so in a random sample of a population, as in a
clinic setting. In line with this, Grødum et al34 showed that normaltension glaucoma, unilateral glaucoma, and better visual fields
were more common in random populations compared to routine
clinical glaucoma practice. This may suggest that even mild diseases are easily be missed in the population.
In summary, the inability to clearly distinguish between early
glaucoma and normal variants is one of the major issues in
glaucoma and it has persisted despite technological improvements, including teleophthalmologic innovations that may further
aggravate the problem.
In the modeling phase of our study, definition criteria and
reference conditions were aimed to be as sensitive as possible to
cover all possible diseases. As the prevalence of open-angle
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glaucoma among adults in the US was stated to be 1.8% over
the age of 40,35 this nonpractically high rate showed us the
diagnostic tests “abnormality” rate in a more general population.
In this regard, our study is an indicator of how large the positive
screening findings might be in the population.
False positives generate direct costs due to unneeded further
clinical examinations and excessive testing which may affect the
participants’ quality of life. Even in face-to-face examination, it is
possible to come across the unneeded initiation of treatment due to
the slightest hint in ophthalmic screening. Therefore, mass ophthalmic screening and over-reliance of these techniques in teleophthalmology might lead to overtreatment, unnecessary
medication costs, follow-up visits, and the risks of side effects
without much gain. We believe the problems related to underdiagnosis and overtreatment can be tackled by creating a proper, welldesigned teleophthalmologic model. For our future studies, we plan
to continuously modify our algorithm based on lesson learned to
decrease the false positive to create more accurate references.
Danish teleophthalmology platform is a good example to
overcome this challenge.36 It was a real-world, large-scale, ehealth based teleophthalmologic model. The authors of this study
point out the requirement of an e-health model due to the
dramatically risen eye care patients and concomitant referral
system emergency. Their strategy was established to lighten
the burden of reference system and it was mainly designed with
a risk-stratified approach. According to the findings they lead the
patients to an optometrist, telemedical service, or National Danish
eye care service in the appropriate timing in one of the acute,
subacute, and nonacute categories. Observing the group of
patients with borderline or subacute findings in the telemedical
service before referring them to the ophthalmology clinic is a
well-thought model that optimizes the health care source. This
would be an inspirational model for us in a future study.
Undoubtedly, devices cannot diagnose the patients and each
condition requires a comprehensive assessment of personal history,
risk factors, examination, and screening findings. In traditional
clinical practice, information gained from the examination leads to
ordering diagnostic tests where the clinician can then decide the
probability of disease being present. The study we designed with
this teleophthalmologic model is quite the opposite, beginning with
a comprehensive screening which then leads to face-to-face examination for definite diagnosis. Despite the existence of potential
issues, we believe technology-based teleophthalmologic approach
will be the inevitable method in the near future. Teleophthalmology
is an expanding domain that could mitigate resource-incentive
aspects of image analysis, nonmydriatic fundus photographs and
remote interpretation, which have been used smoothly in both rural
and urban settings.3 Fast technological advancements make perimeters, fundus cameras, and OCT machines easily accessible with
less costs, all of which will be performed in a widespread manner.
Monitorization and documentation of findings for future comparisons constitute the personal normative data system. High reproducibility of testing allows each individual to have his or her own
normative data and individualize early detection of baseline
changes rather than relying on population norms.37 Even at the
time of this writing, interesting innovations are ongoing with the
incorporation of artificial intelligence and deep learning to ophthalmic diagnosis.38–46 We believe these methods will help get an
effective diagnosis with teleophthalmologic models, and these
models will be an ideal implication area for these innovations.
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The effective, applicable technology-based eye screening
models require not only comprehensive screening devices, but
also detailed questionnaire forms to detect personal risk factors
effectively. Thus, the questionnaire form was prepared to take the
necessary information from participants as fast and as effectively
as possible. It included specific questions which might be risk
factors for major eye diseases. Dental health and glaucoma were
also found to be related in a prospective cohort study of men with
glaucoma. Pasquale et al also identified poor oral health and
recent tooth loss as risk factors for primary open-angle glaucoma
in men.47 Somewhat contrary with the findings of Pasquale et al,
in our analysis, we did not find any significant increase in risks
associated with subjects that did not have a dental examination for
more than 2 years.
In addition to the questionnaire form, basic systemic examination findings are also assessed as risk factors for eye diseases.
Substantial proportions of participants had newly detected diabetes, hypertension, and conditions that predisposed them to ocular
disease.48,49 In all groups, only 25% of the participants had a
healthy HbA1c level, only the blood pressure of 33% was in
normal limits, and only 28% had a normal range of BMI. The
percentages of the participants who have healthy HbA1c levels
and a normal range of blood pressure were even less in the
referred group. Similarly, as seen in Table 5, both self-reported
systemic diseases and systemic evaluations that are done by our
mobile unit are among the significant risk factors in this group.
The systemic risk factors were found more than literature-based
anticipations.50–52 We believe that our findings show that there is
a great need for a comprehensive public health study in New York
City. Our study also points to interesting spots for future epidemiological and public health studies.
In Table 5, the effects of all parameters (demographic
characteristics as well as systemic and ocular findings) were
evaluated using an RRR calculation. This analysis was also
complemented with a Bayesian logistic regression as presented
in Table 6. As it was a pilot study, the deficiencies were
detected—detailed statistical evaluation of the parameters will
help improve our models. Different thresholds for risk groups,
giving different weights to each technique instead of the either
positive rule, modeling combined testing for diagnosis, and
priority queuing for reference, shall further be investigated. All
these possibilities for future research require a clinically integrated model to see the coherent match between the teleophthalmologic model and clinical diagnosis. These future studies may
shed a further light on the clinical significance of our results
beyond the statistically significant findings we presented in the
current paper.
One major limitation of our study is that it was not designed
with a consecutive clinical and comprehensive eye examination.
Even though we aimed to understand the true-false-positivenegative diagnosis rates with the follow-up calls, results presented
in Table 7 suggest that this was not really feasible. As seen in
Table 7, first, the rate of answered phone calls was quite limited.
The rate of follow-up examinations done by ophthalmologists was
considerably limited. Follow-up visit results were obtained from
the participants through phone conversations by using special
follow-up questionnaire forms. Therefore, we had to rely on
participants’ self-reports about disease confirmation or contradiction. All these factors were the barriers to report accurate truefalse positive-negative diagnosis. This would constitute a further

ß 2021 Asia-Pacific Academy of Ophthalmology.

Real Teleophthalmology for the Detection

motivation to construct a health record integrated teleophthalmologic model. We believe such a potentially integrated system
would provide a well-settled diagnostic prediction model and risk
analysis with demographics and past medical history.

CONCLUSION
In conclusion, our study demonstrates the feasibility of realtime, ophthalmology screening in high risk and low socioeconomics minorities of New York City. Additionally, it has the
potential to drastically improve access to ophthalmic care while
presenting an opportunity to share health information with the
community. We obtained important results that are relevant to the
population; however, we also believe that our study has room to
improve upon the sensitivity and specificity. We plan to perform
further research studies that will be guided by this pilot study.
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